Changchun Historical Income Statement
| 688276 Stock | 26.37 0.29 1.11% |
Historical analysis of Changchun BCHT income statement accounts such as Net Interest Income of 6.6 M, Interest Income of 9.7 M or Interest Expense of 669.7 K can show how well Changchun BCHT Biotechnology performed in making a profits. Evaluating Changchun BCHT income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Changchun BCHT's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Changchun BCHT Biote latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Changchun BCHT Biote is a good buy for the upcoming year.
Changchun |
About Changchun Income Statement Analysis
Changchun BCHT Biote Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Changchun BCHT shareholders. The income statement also shows Changchun investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Changchun BCHT Income Statement Chart
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Changchun BCHT Biotechnology minus its cost of goods sold. It is profit before Changchun BCHT operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Changchun BCHT's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Changchun BCHT Biote current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Changchun BCHT Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. The current year's EBITDA is expected to grow to about 292.7 M, whereas Tax Provision is forecasted to decline to about 33.3 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.1B | 934.2M | 1.6B | 1.3B | Total Revenue | 1.2B | 1.1B | 1.8B | 1.4B |
Changchun BCHT income statement Correlations
Click cells to compare fundamentals
Changchun BCHT Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Changchun Stock
Changchun BCHT Biote Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Changchun BCHT shareholders. The income statement also shows Changchun investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).